These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 19326384

  • 1. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F, Manetti F, Carraro F, Naldini A, Maga G, Crespan E, Schenone S, Bruno O, Brullo C, Botta M.
    ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
    [Abstract] [Full Text] [Related]

  • 2. C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines.
    Santucci MA, Corradi V, Mancini M, Manetti F, Radi M, Schenone S, Botta M.
    ChemMedChem; 2009 Jan; 4(1):118-26. PubMed ID: 19039816
    [Abstract] [Full Text] [Related]

  • 3. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C, Magnani M, Schenone S, Botta M.
    Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033
    [Abstract] [Full Text] [Related]

  • 4. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R, Daga PR, Banerjee R, Iqbal J.
    Bioorg Med Chem; 2005 Aug 01; 13(15):4704-12. PubMed ID: 15914012
    [Abstract] [Full Text] [Related]

  • 5. Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
    Puttini M, Redaelli S, Moretti L, Brussolo S, Gunby RH, Mologni L, Marchesi E, Cleris L, Donella-Deana A, Drueckes P, Sala E, Lucchini V, Kubbutat M, Formelli F, Zambon A, Scapozza L, Gambacorti-Passerini C.
    Haematologica; 2008 May 01; 93(5):653-61. PubMed ID: 18367480
    [Abstract] [Full Text] [Related]

  • 6. Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
    Dreassi E, Zizzari AT, Falchi F, Schenone S, Santucci A, Maga G, Botta M.
    Eur J Med Chem; 2009 Sep 01; 44(9):3712-7. PubMed ID: 19410338
    [Abstract] [Full Text] [Related]

  • 7. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K, Lindner M, Pianwanit S, Kokpol S, Sippl W.
    Eur J Med Chem; 2009 Apr 01; 44(4):1383-95. PubMed ID: 18976834
    [Abstract] [Full Text] [Related]

  • 8. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G, Saxena AK.
    J Chem Inf Model; 2006 Apr 01; 46(6):2579-90. PubMed ID: 17125198
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.
    Xiao J, Guo Z, Guo Y, Chu F, Sun P.
    Protein Eng Des Sel; 2006 Feb 01; 19(2):47-54. PubMed ID: 16339768
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines.
    Schenone S, Brullo C, Bruno O, Bondavalli F, Mosti L, Maga G, Crespan E, Carraro F, Manetti F, Tintori C, Botta M.
    Eur J Med Chem; 2008 Dec 01; 43(12):2665-76. PubMed ID: 18342402
    [Abstract] [Full Text] [Related]

  • 11. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines.
    Manetti F, Brullo C, Magnani M, Mosci F, Chelli B, Crespan E, Schenone S, Naldini A, Bruno O, Trincavelli ML, Maga G, Carraro F, Martini C, Bondavalli F, Botta M.
    J Med Chem; 2008 Mar 13; 51(5):1252-9. PubMed ID: 18257513
    [Abstract] [Full Text] [Related]

  • 12. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T, Ortore G, Santos MA, Marques SM, Nuti E, Rossello A, Martinelli A.
    J Chem Inf Model; 2009 Jul 13; 49(7):1715-24. PubMed ID: 19522467
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cells.
    Manetti F, Pucci A, Magnani M, Locatelli GA, Brullo C, Naldini A, Schenone S, Maga G, Carraro F, Botta M.
    ChemMedChem; 2007 Mar 13; 2(3):343-53. PubMed ID: 17295370
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors.
    Lü S, Luo Q, Hao X, Li X, Ji L, Zheng W, Wang F.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):6964-8. PubMed ID: 22033461
    [Abstract] [Full Text] [Related]

  • 15. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD, Hamza A, Liu J, Zhan CG.
    J Chem Inf Model; 2008 Sep 01; 48(9):1760-72. PubMed ID: 18717540
    [Abstract] [Full Text] [Related]

  • 16. Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses.
    Sharma P, Ghoshal N.
    J Chem Inf Model; 2006 Sep 01; 46(4):1763-74. PubMed ID: 16859308
    [Abstract] [Full Text] [Related]

  • 17. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N, Senkovich O, Walker K, Wright DL, Anderson AC, Rosowsky A, Ananthan S, Shinkre B, Velu S, Chattopadhyay D.
    Proteins; 2008 Dec 01; 73(4):889-901. PubMed ID: 18536013
    [Abstract] [Full Text] [Related]

  • 18. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M, Weigt M, Wiese M.
    Eur J Med Chem; 2009 Oct 01; 44(10):4070-82. PubMed ID: 19515462
    [Abstract] [Full Text] [Related]

  • 19. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK, Achaiah G, Sastry GN.
    Eur J Med Chem; 2008 Apr 01; 43(4):830-8. PubMed ID: 17706839
    [Abstract] [Full Text] [Related]

  • 20. Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies.
    Gambacorti-Passerini C, Gasser M, Ahmed S, Assouline S, Scapozza L.
    Leukemia; 2005 Jul 01; 19(7):1267-9. PubMed ID: 15858616
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.